ContractopenPA
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
National Institutes of HealthDescription
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII. Recipient: VENATORX PHARMACEUTICALS INC Award Amount: $25.04M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $25,040,000
Deadline
January 18, 2027
Geographic Scope
PA
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score